ArticleJournal of Cancer2026

RNF216 as a Promising Biomarker for Prognosis, Immunotherapy, and Chemotherapy in LIHC: A Comprehensive Pan-Cancer Analysis and Experimental Validation.

Ke Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.